Tuesday, 23 April 2019

Teva scraps cluster headache program

Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)